Skip to content
NHQualityCampaign.orgIndependent nursing home quality resource
Quick AnswersFor professionals

What Is a Gradual Dose Reduction (GDR) in Nursing Homes?

A gradual dose reduction (GDR) is a stepwise taper of a psychotropic drug to find the lowest effective dose or stop it. Federal rules require GDRs plus behavioral interventions unless clinically contraindicated, with attempts in two separate quarters during the first year.

Updated 2 min readHow we research
Scored white tablets that can be split for dose changes
Photo: rawpixel (CC0 1.0 (public domain)). Credits

The federal GDR requirement

Residents who use psychotropic drugs must receive gradual dose reductions and behavioral interventions, unless clinically contraindicated, in an effort to discontinue them (42 CFR 483.45(e)). CMS surveyor guidance expects a GDR attempt in two separate quarters, with at least one month between attempts, within the first year after admission on the drug or after it is started, then at least annually. PRN psychotropic orders are generally limited to 14 days, and PRN antipsychotics cannot be renewed without the prescriber evaluating the resident.

When a GDR is clinically contraindicated

A GDR may be contraindicated when target symptoms returned or worsened after a recent attempt, or for some enduring conditions. The prescriber must document the specific clinical rationale, not a template phrase. Under the revised Appendix PP guidance effective 28 April 2025 (CMS memo QSO-25-14-NH), these requirements are surveyed under F605 (formerly F758 before April 2025): psychotropics without adequate indication, monitoring, non-drug interventions and GDR documentation can be cited as chemical restraints.

A practical GDR workflow

  1. 1
    Identify
    List every resident on antipsychotics, antidepressants, anxiolytics and hypnotics with start dates and last GDR.
  2. 2
    Review
    Pharmacist medication regimen review and interdisciplinary team input on target behaviors and non-drug strategies.
  3. 3
    Taper and monitor
    Reduce in small steps (scored tablets help) and track target symptoms and side effects with a behavior log.
  4. 4
    Document
    Record the outcome, or the prescriber’s rationale if contraindicated, and the next review date.

Individual tapering schedules are a prescriber decision. Drug-specific references such as quetiapine prescribing information help teams check available strengths, and a versioned SOP builder keeps your GDR policy current. More in antipsychotic reduction and medication management.

Frequently asked questions

How often is a GDR required?

For psychotropic drugs, CMS guidance expects GDR attempts in two separate quarters, at least one month apart, during the first year after admission on the drug or after it is started. After the first year, a GDR should be attempted at least annually, unless clinically contraindicated and documented.

Who decides if a GDR is clinically contraindicated?

The prescribing practitioner, with input from the interdisciplinary team and the consultant pharmacist. The record must explain why a reduction is likely to impair function or worsen symptoms, for example a documented relapse after a recent attempt. A generic statement is not enough.

Does GDR apply to antidepressants and sleep medications?

Yes. The requirement applies to all psychotropic drugs, defined as drugs that affect brain activity tied to mental processes and behavior. That includes antipsychotics, antidepressants, anti-anxiety drugs and hypnotics.

Sources

  1. 42 CFR 483.45: Pharmacy services (eCFR)
  2. CMS State Operations Manual, Appendix PP (guidance to surveyors for LTC facilities)
  3. CMS: National Partnership to Improve Dementia Care, antipsychotic medication use data report
  4. American Geriatrics Society 2023 Updated Beers Criteria (J Am Geriatr Soc)

Medical disclaimer. This page is general education, not medical, legal or financial advice, and it does not replace the judgment of a qualified clinician who knows the resident. Do not start, stop or change any medication without talking to the prescriber. In an emergency, call 911.

Independent resource. NHQualityCampaign.org is an independent educational resource. It is not affiliated with, endorsed by or operated by the Centers for Medicare & Medicaid Services (CMS), the U.S. Department of Health and Human Services (HHS), any government agency, or the original Advancing Excellence in America’s Nursing Homes campaign or its sponsors. Historical campaign information is summarized with attribution for educational purposes.